NICE reveals ‘health technology evaluation methods’ review
The review will cover NICE’s technology appraisals, highly specialised technologies, medical technologies, and diagnostics assessment programmes.
Read More
Tag: medical technologies
- CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
